Open figure viewer
Significance
Government authorities, including in the United States, are speeding up licensing for clinical trials of these controlled drugs. Substantial philanthropic funding supports psychedelic medicine and campaigns for regulated use of these drugs, including for treatment of PTSD, chronic depression and addiction.
Impacts
Biotechnology companies expect psychedelic therapies to become mainstream over the next decade.
Relaxation of drug laws could trigger increased investment in research and development.
Legal production of psychedelic drugs will have a limited impact on criminal production, which is driven by demand for recreational use.
Keywords:
Pharm, biotech & life sciences,
industry,
international relations,
politics,
social,
foreign investment,
health,
investment,
narcotics,
pharmaceutical,
private sector,
regulation,
science,
International,
LA/C,
Germany,
Mexico,
Netherlands,
Peru,
United Kingdom,
United Nations,
United States
© Oxford Analytica 2021. All rights reserved. This content contains general information about geopolitical, macroeconomic and social developments or (where stated) other matters. It does not contain advice or recommendations that may be relied on. Where links to external websites are provided, this does not indicate that Oxford Analytica or Emerald agree with, endorse or have checked for accuracy the contents of said sites.
2021
You do not currently have access to this content.
